COMP <GO>
EMR vs GEV // NET PROFIT MARGIN
Emerson Electric Company (NYSE) VS. GE Vernova Inc. (NYSE) • 15-METRIC TALLY: EMR 11
— GEV 3
▲ NET PROFIT MARGIN LEADER: GEV
LAST: $164.94 (-3.40%) • MKT CAP: $95.24B
net-margins
12.70%
LAST: $857.87 (-3.38%) • MKT CAP: $234.99B
net-margins
12.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMR VS. GEV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMR | GEV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.80% | 19.80% | +33.00 | EMR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | 4.40% | +5.30 | EMR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 30.9x | 87.5x | -56.60 | EMR | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | 1.39% | +1.41 | EMR | /fcf-yield <GO> |
| Operating Margin | 15.50% | 3.60% | +11.90 | EMR | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 12.70% | 12.80% | -0.10 | GEV | /net-margins <GO> |
| Revenue Growth (YoY) | 3.00% | 9.00% | -6.00 | GEV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.25% | 0.12% | +1.13 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.80 | 3.58 | +1.22 | EMR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | EMR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.1 | 45.8 | +18.30 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 1.32 | +0.02 | EMR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.6x | 44.7x | -6.10 | EMR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.24B | $234.99B | -$139.75B | GEV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMR REV | GEV REV | EMR GROSS % | GEV GROSS % | EMR FCF | GEV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.02B | $38.07B | 52.8% | 19.8% | $2.67B | $3.27B |
| FY 2024 | $17.49B | $34.94B | 50.8% | 17.4% | $2.91B | $1.01B |
| FY 2023 | $15.16B | $33.24B | — | — | -$45.4M | -$309.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMR // BETA 1.34
GEV // BETA 1.32